[Abstracts Only] Biologics Found to be Effective for Ulcerative Colitis in Industry-funded Trials
30 Sep, 2019 | 00:11h | UTCSee also: Ulcerative Colitis: One Biologic Investigated, Two Others Compared – NEJM Journal Watch (free)
Original Studies: Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis – New England Journal of Medicine (link to abstract – $ for full-text) AND Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis – New England Journal of Medicine (link to abstract – $ for full-text)